1999
DOI: 10.1016/s0006-8993(98)01122-6
|View full text |Cite
|
Sign up to set email alerts
|

Behavioural analysis and susceptibility to CNS injury of four inbred strains of mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

7
59
0

Year Published

2000
2000
2014
2014

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 106 publications
(66 citation statements)
references
References 48 publications
7
59
0
Order By: Relevance
“…NeuN immunoreactivity in the CA3 subregion was not decreased in either wild-type or galectin-1 knockout mice (Figure 4b-e and j), indicating no apparent neuronal loss in the CA3 subregion. The mouse 129 strain used in this experiment is known to respond mildly to kainate as compared with other mouse strains, 22 and this may be the reason why we did not observe a loss of pyramidal cells in CA3. The extent of gliosis in the CA3 subregion was assessed by GFAP immunoreactivity, and we found that, after kainate administration, the GFAP index in Figure 3 Isolated primary astrocytes express and secrete galectin-1 in vitro.…”
Section: Resultsmentioning
confidence: 78%
“…NeuN immunoreactivity in the CA3 subregion was not decreased in either wild-type or galectin-1 knockout mice (Figure 4b-e and j), indicating no apparent neuronal loss in the CA3 subregion. The mouse 129 strain used in this experiment is known to respond mildly to kainate as compared with other mouse strains, 22 and this may be the reason why we did not observe a loss of pyramidal cells in CA3. The extent of gliosis in the CA3 subregion was assessed by GFAP immunoreactivity, and we found that, after kainate administration, the GFAP index in Figure 3 Isolated primary astrocytes express and secrete galectin-1 in vitro.…”
Section: Resultsmentioning
confidence: 78%
“…To assess HuRs involvement in KAinduced neuronal dysfunction, we treated control (Elavl1 fl/fl and CamKIICre − Elavl fl/fl ) and CN-KO mice with two systemic doses of KA (20 and 30 mg/kg). These doses were previously reported to induce a mild excitotoxic response in the genetic background of our mutations (C57BL/6), 19,20 which is partially resistant to KA challenges. Following KA administration, mice were initially scored for the extent of epileptic seizures occurring within the first 3 h. In control mice, seizure-rating scores increased by 10 min, peaked between 20 and 30 min and gradually subsided thereafter.…”
Section: Elavl1mentioning
confidence: 84%
“…15 Experiments involving the administration of KA (intraperitoneal; K0250; Sigma, St. Louis, MO, USA) were supervised by Fleming's Veterinarian. Seizure severity was quantified via a 5-pointed rating scale 20 that included the frequency, latency and duration of shakes, convulsions, tonic-clonic seizures and death by two observers (OP and DLK). Surviving mice returned to their cages 3 h after the cessation of seizure activity or killed for histology.…”
Section: Methodsmentioning
confidence: 99%
“…Although C57BL/6 mice are known to be less susceptible to kainate-induced seizures 82,83 and seizureinduced damage, 84 Morrison and collegues 79 demonstrated significant neuronal damage in the CA3 and CA1 subregions of the hippocampus in p53 wild-type mice (129/SvEv6C57BL/6 background) despite the genetic contribution from the C57BL/6 strain. Others have also reported significant induction of neuronal damage in the CA3 and CA1 subregions of the hippocampus in C57BL/6 mice in response to kainate-induced seizures.…”
Section: The Relationship Between P53 Expression and Neuronal Cell Deathmentioning
confidence: 99%